News

AtriCure, Inc., the leader in surgical ablation for the treatment of atrial fibrillation (AF), has announced FDA approval of the ABLATE Post Approval Study (PAS). This landmark three-year, 350-patient study is a follow-up to the company’s...

“Anticoagulation Centers of Excellence” will launch to improve clinic practices nationwide The Anticoagulation Forum (AC Forum) has embarked on an exciting new project called “Anticoagulation Centers of Excellence.” A Fall 2012 launch is...

Female electrophysiologists from around the world gathered on August 28th, 2012 at the European Society of Cardiology Congress to attend the EPIC Alliance’s scientific session “The Heart of the Matter.” The EPIC Alliance (Electrophysiologist...

The Valley Hospital Collaboration with State Research Institute of Circulation Pathology in Siberia Finds Treatment on Kidney Has Positive Impact on the Heart Cardiologists from The Valley Health System have collaborated with counterparts in...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it will display the LifeVest® Wearable Defibrillator in Booth #312 at the Heart Failure Society of America (HFSA) Annual Meeting being...

A new pre-clinical study demonstrates how stem cells may significantly reduce the ripple-effect damage caused by a heart attack. The study, by researchers at the University of Maryland School of Medicine in Baltimore, appears in the September...

Research Suggests More Durable PV Isolation with HeartLight Laser vs. Cryoballoon Ablation CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new data...

New atrial fibrillation motion graphic launches to further patient education Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial fibrillation...

Medtronic-Supported Study is One of First to Evaluate Improvements, by Race, in the Use of Heart Failure Therapies in the Outpatient Setting Medtronic, Inc. announced new findings from the landmark IMPROVE HF (Registry to Improve the Use of...